Evidence map›Paper›PMID 28276062›Full record

ArticleEpilepsia2017

ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.

Ingrid E Scheffer, Samuel Berkovic, Giuseppe Capovilla, Mary B Connolly, Jacqueline French, Laura Guilhoto, Edouard Hirsch, Satish Jain, Gary W Mathern, Solomon L Moshé and 6 more

7 registry-linked trialsAbstract readConsensus Statement
In one paragraph

Article in Epilepsia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 7 registered trials, which are not on this map. Cited by 2,030 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,030citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04343352 nacompletednot on this mapstarted 2020, after this paper: background citation

Randomized Controlled Study: Evaluation of the Efficiency of Mobile Application for Parents of Children With Epilepsy

TypeinterventionalSponsorDILEK SAYIKRan2020 to 2022Enrolled60ConditionsChild, Epilepsy, Education, Mobile ApplicationArmsimplementation of mobile epilepsy training program
NCT05297695 phase2 / phase3completednot on this mapstarted 2022, after this paper: background citation

Effect of Treating Helicobacter Pylori Infection on Seizure Frequency in Children With Drug-Resistant Idiopathic Generalized Epilepsy

TypeinterventionalSponsorSohag UniversityRan2022 to 2023Enrolled126ConditionsEpilepsy, Generalized, Helicobacter Pylori InfectionArmsTriple therapy for H. pylori infection
NCT05450822 recruitingnot on this mapstarted 2022, after this paper: background citation

The BrainDrugs-Epilepsy Study: A Prospective Open-label Cohort Precision Medicine Study in Epilepsy

TypeobservationalSponsorGitte Moos KnudsenRan2022 to 2031Enrolled550ConditionsEpilepsyArmsLevetiracetam, Levetiracetam Tablets, Lamotrigine tablet
NCT05670847 phase2 / phase3recruitingnot on this mapstarted 2023, after this paper: background citation

Efficacy of Ketone Esters for Children With Drug Resistant Epilepsy

TypeinterventionalSponsorSohag UniversityRan2023 to 2025Enrolled60ConditionsDrug Resistant EpilepsyArmsExogenous ketone ester
NCT06223334 unknown statusnot on this mapstarted 2023, after this paper: background citation

Clinico-etiological Profile of Epileptic Syndromes in Infants and Early Childhood

TypeobservationalSponsorAl-Azhar UniversityRan2023 to 2025Enrolled140ConditionsEpileptic SyndromesArmsNo intervention
NCT06442748 phase3recruitingnot on this mapstarted 2024, after this paper: background citation

Short Versus Long-term Levetiracetam in Brain Tumors: A Phase 3 Randomized Controlled Trial (LIBRA)

TypeinterventionalSponsorTata Memorial CentreRan2024 to 2031Enrolled604ConditionsSeizures, Brain Tumors, Antiepileptics, LevetiracetamArmsLevetiracetam
NCT06550726 narecruitingnot on this mapstarted 2024, after this paper: background citation

High-resolution Multi-parametric Magnetic Resonance Imaging for Focal Epilepsy

TypeinterventionalSponsorChinese University of Hong KongRan2024 to 2028Enrolled66ConditionsEpilepsies, PartialArmsMagnetic Resonance Imaging
3 · Its place in the literature

Who cites it

2,030 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Immune dysregulation and epileptogenesis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  20. Article

1,970 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Ingrid E SchefferDepartment of Medicine, The University of Melbourne, Austin Health, Melbourne, Victoria, Australia.
Samuel BerkovicDepartment of Medicine, The University of Melbourne, Austin Health, Melbourne, Victoria, Australia.
Giuseppe CapovillaChild Neuropsychiatry Department, Epilepsy Center, C. Poma Hospital, Mantova, Italy.
Mary B ConnollyDepartment of Pediatrics, British Columbia's Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Jacqueline FrenchDepartment of Neurology, NYU School of Medicine, New York, New York, U.S.A.
Laura GuilhotoDepartment of Neurology, Federal University of São Paulo; University Hospital, University of São Paulo, São Paulo, Brazil.
Edouard HirschUniversity Hospital INSERM U 964, Strasbourg, France.
Satish JainIndian Epilepsy Centre, New Delhi, India.
Gary W MathernDepartments of Neurosurgery, Psychiatry and Biobehavioral Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, U.S.A.
Solomon L MoshéSaul R. Korey Department of Neurology, Dominick P. Purpura Department of Neuroscience and Department of Pediatrics, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, U.S.A.
Douglas R NordliDivision of Neurology, Children's Hospital Los Angeles, Los Angeles, California, U.S.A.
Emilio PeruccaC. Mondino National Neurological Institute and Clinical Pharmacology Unit, University of Pavia, Pavia, Italy.
Torbjörn TomsonDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Samuel WiebeDepartments of Clinical Neurosciences and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Yue-Hua ZhangDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Sameer M ZuberiPaediatric Neurosciences Research Group, Fraser of Allander Neurosciences Unit, Royal Hospital for Children, Glasgow, United Kingdom.

Funding

The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Public Engagement CoreU54NS100064 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ENGEL, JEROME NONE, GALANOPOULOU, ARISTEA S · 2017 to 2021
$21.7M
Consequences of Prolonged Febrile Seizures in ChildhoodR01NS043209 · NINDS · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI SHINNAR, SHLOMO · 2003 to 2012
$21.5M
Consequences of Prolonged Febrile Seizures in ChildhoodR37NS043209 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SHINNAR, SHLOMO · 2013 to 2019
$11.4M
NINDS NIH HHS R01 NS043209NINDS NIH HHS R37 NS043209NINDS NIH HHS U54 NS100064
6 · The paper itself

Abstract

The International League Against Epilepsy (ILAE) Classification of the Epilepsies has been updated to reflect our gain in understanding of the epilepsies and their underlying mechanisms following the major scientific advances that have taken place since the last ratified classification in 1989. As a critical tool for the practicing clinician, epilepsy classification must be relevant and dynamic to changes in thinking, yet robust and translatable to all areas of the globe. Its primary purpose is for diagnosis of patients, but it is also critical for epilepsy research, development of antiepileptic therapies, and communication around the world. The new classification originates from a draft document submitted for public comments in 2013, which was revised to incorporate extensive feedback from the international epilepsy community over several rounds of consultation. It presents three levels, starting with seizure type, where it assumes that the patient is having epileptic seizures as defined by the new 2017 ILAE Seizure Classification. After diagnosis of the seizure type, the next step is diagnosis of epilepsy type, including focal epilepsy, generalized epilepsy, combined generalized, and focal epilepsy, and also an unknown epilepsy group. The third level is that of epilepsy syndrome, where a specific syndromic diagnosis can be made. The new classification incorporates etiology along each stage, emphasizing the need to consider etiology at each step of diagnosis, as it often carries significant treatment implications. Etiology is broken into six subgroups, selected because of their potential therapeutic consequences. New terminology is introduced such as developmental and epileptic encephalopathy. The term benign is replaced by the terms self-limited and pharmacoresponsive, to be used where appropriate. It is hoped that this new framework will assist in improving epilepsy care and research in the 21st century.

Indexed as

Terminology as TopicEpilepsyHumansInternational AgenciesClassificationEpilepsy syndromesEtiologyTerminology

Identifiers

PMID28276062
PMCPMC5386840

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

and 1 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.